These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 24799303

  • 1. Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.
    Hofer J, Giner T, Józsi M.
    Semin Thromb Hemost; 2014 Jun; 40(4):431-43. PubMed ID: 24799303
    [Abstract] [Full Text] [Related]

  • 2. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [Abstract] [Full Text] [Related]

  • 3. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R, Jarmużek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, Zachwieja K, Ardissino G, Hofer J.
    Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
    [Abstract] [Full Text] [Related]

  • 4. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI.
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [Abstract] [Full Text] [Related]

  • 5. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
    Fung WW, Chao AC, Pang WF, Wong RS, Chow KM, Szeto CC.
    BMC Nephrol; 2024 May 14; 25(1):164. PubMed ID: 38745129
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.
    Am J Reprod Immunol; 2015 Oct 14; 74(4):345-56. PubMed ID: 26011580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct 14; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 13. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
    Szarvas N, Szilágyi Á, Tasic V, Nushi-Stavileci V, Sofijanova A, Gucev Z, Szabó M, Szabó A, Szeifert L, Reusz G, Rusai K, Arbeiter K, Müller T, Prohászka Z.
    Ital J Pediatr; 2014 Dec 11; 40():101. PubMed ID: 25496981
    [Abstract] [Full Text] [Related]

  • 14. Successful living-related renal transplantation in a patient with factor H antibody-associated atypical hemolytic uremic syndrome.
    Hofer J, Giner T, Cortina G, Jungraithmayr T, Masalskiene J, Dobiliene D, Mitkiene R, Pundziene B, Rudaitis S.
    Pediatr Transplant; 2015 Aug 11; 19(5):E121-5. PubMed ID: 26037622
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C, Józsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb 11; 101(2):227-32. PubMed ID: 19190803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O, Balzamo E, Charbit M, Biebuyck-Gougé N, Salomon R, Dragon-Durey MA, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2010 May 11; 55(5):923-7. PubMed ID: 20202729
    [Abstract] [Full Text] [Related]

  • 19. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
    Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V, HUS International.
    Pediatr Nephrol; 2016 Jan 11; 31(1):15-39. PubMed ID: 25859752
    [Abstract] [Full Text] [Related]

  • 20. The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.
    Kim JJ, McCulloch M, Marks SD, Waters A, Noone D.
    Clin Nephrol; 2015 Jan 11; 83(1):49-56. PubMed ID: 24131678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.